Objective benefit of nifedipine in the treatment of Raynaud's phenomenon: Double-blind controlled study-Reference-Cited by-同舟云学术

Objective benefit of nifedipine in the treatment of Raynaud's phenomenon: Double-blind controlled study

Published:1986-04 Issue:4 Volume:80 Page:623-625
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

White Christopher J.,Phillips William A.,Abrahams Lisa A.,Watson Thomas D.,Singleton Peter T.

Publisher

Elsevier BV

Subject

General Medicine

Reference6 articles.

1. Ca-blockers and peripheral circulation—physiological viewpoints;Ekelund;Acta Pharmacol Toxicol (Copenh),1978

2. Effects of calcium and calcium antagonists on the excitation-contraction coupling in striated and smooth muscle;Andersson;Acta Pharmacol Toxicol (Copenh),1978

3. Nifedipine and Raynaud's phenomenon (letter);Kahan;N Engl J Med,1981

4. Calcium channel blockers and Raynaud's disease (letter);Vayssairat;N Engl J Med,1981

5. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon;Rodeheffer;N Engl J Med,1983

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium channel blockers for primary and secondary Raynaud's phenomenon;Cochrane Database of Systematic Reviews;2017-12-13

2. Calcium channel blockers for primary Raynaud's phenomenon;Cochrane Database of Systematic Reviews;2016-02-25

3. Calcium channel blockers for primary Raynaud's phenomenon;Cochrane Database of Systematic Reviews;2014-01-30

4. Laser Doppler Imaging para quantificação do fluxo sanguíneo de polpa digital em condições basais e após estímulo frio em pacientes com esclerose sistêmica;Revista Brasileira de Reumatologia;2010-04

5. Management of Raynaud’s Phenomenon in the Patient with Connective Tissue Disease;Current Treatment Options in Cardiovascular Medicine;2010-03-06